424 related articles for article (PubMed ID: 37052791)
1. Exploring the Therapeutic Effect of Neurotrophins and Neuropeptides in Neurodegenerative Diseases: at a Glance.
Rahman MM; Islam MR; Supti FA; Dhar PS; Shohag S; Ferdous J; Shuvo SK; Akter A; Hossain MS; Sharma R
Mol Neurobiol; 2023 Aug; 60(8):4206-4231. PubMed ID: 37052791
[TBL] [Abstract][Full Text] [Related]
2. Neurotrophins.
Dechant G; Neumann H
Adv Exp Med Biol; 2002; 513():303-34. PubMed ID: 12575826
[TBL] [Abstract][Full Text] [Related]
3. Can Brain-derived Neurotrophic Factor (BDNF) Mimetics be a Way Out for Neurodegenerative Diseases?
Korkmaz OT
Curr Pharm Des; 2023; 29(4):246-250. PubMed ID: 36705236
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances on the Role of Brain-Derived Neurotrophic Factor (BDNF) in Neurodegenerative Diseases.
Azman KF; Zakaria R
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743271
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases.
Duarte-Neves J; Pereira de Almeida L; Cavadas C
Neurobiol Dis; 2016 Nov; 95():210-24. PubMed ID: 27461050
[TBL] [Abstract][Full Text] [Related]
6. Regulation of neuropeptide expression in the brain by neurotrophins. Potential role in vivo.
Carnahan J; Nawa H
Mol Neurobiol; 1995; 10(2-3):135-49. PubMed ID: 7576304
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington's disease.
Alberch J; Pérez-Navarro E; Canals JM
Brain Res Bull; 2002 Apr; 57(6):817-22. PubMed ID: 12031278
[TBL] [Abstract][Full Text] [Related]
8. Neurotrophin signalling: novel insights into mechanisms and pathophysiology.
Mitre M; Mariga A; Chao MV
Clin Sci (Lond); 2017 Jan; 131(1):13-23. PubMed ID: 27908981
[TBL] [Abstract][Full Text] [Related]
9. In vivo mitochondrial inhibition alters corticostriatal synaptic function and the modulatory effects of neurotrophins.
Mendoza E; Miranda-Barrientos JA; Vázquez-Roque RA; Morales-Herrera E; Ruelas A; De la Rosa G; Flores G; Hernández-Echeagaray E
Neuroscience; 2014 Nov; 280():156-70. PubMed ID: 25241069
[TBL] [Abstract][Full Text] [Related]
10. Promoting neurotrophic effects by GPCR ligands.
Jeanneteau F; Chao MV
Novartis Found Symp; 2006; 276():181-9; discussion 189-92, 233-7, 275-81. PubMed ID: 16805430
[TBL] [Abstract][Full Text] [Related]
11. Regulation of AMPAR trafficking in synaptic plasticity by BDNF and the impact of neurodegenerative disease.
Keifer J
J Neurosci Res; 2022 Apr; 100(4):979-991. PubMed ID: 35128708
[TBL] [Abstract][Full Text] [Related]
12. Targeting BDNF signaling by natural products: Novel synaptic repair therapeutics for neurodegeneration and behavior disorders.
Bawari S; Tewari D; Argüelles S; Sah AN; Nabavi SF; Xu S; Vacca RA; Nabavi SM; Shirooie S
Pharmacol Res; 2019 Oct; 148():104458. PubMed ID: 31546015
[TBL] [Abstract][Full Text] [Related]
13. Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.
Pramanik S; Sulistio YA; Heese K
Mol Neurobiol; 2017 Nov; 54(9):7401-7459. PubMed ID: 27815842
[TBL] [Abstract][Full Text] [Related]
14. Neurotrophin signalling in health and disease.
Chao MV; Rajagopal R; Lee FS
Clin Sci (Lond); 2006 Feb; 110(2):167-73. PubMed ID: 16411893
[TBL] [Abstract][Full Text] [Related]
15. The Relation of the Brain-Derived Neurotrophic Factor with MicroRNAs in Neurodegenerative Diseases and Ischemic Stroke.
Eyileten C; Sharif L; Wicik Z; Jakubik D; Jarosz-Popek J; Soplinska A; Postula M; Czlonkowska A; Kaplon-Cieslicka A; Mirowska-Guzel D
Mol Neurobiol; 2021 Jan; 58(1):329-347. PubMed ID: 32944919
[TBL] [Abstract][Full Text] [Related]
16. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders.
Mattson MP; Maudsley S; Martin B
Trends Neurosci; 2004 Oct; 27(10):589-94. PubMed ID: 15374669
[TBL] [Abstract][Full Text] [Related]
17. Expression of neurotrophins in hippocampal interneurons immunoreactive for the neuropeptides somatostatin, neuropeptide-Y, vasoactive intestinal polypeptide and cholecystokinin.
Pascual M; Acsády L; Rocamora N; Freund TF; Soriano E
Neuroscience; 1999; 89(4):1089-101. PubMed ID: 10362297
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor as a drug target for CNS disorders.
Pezet S; Malcangio M
Expert Opin Ther Targets; 2004 Oct; 8(5):391-9. PubMed ID: 15469390
[TBL] [Abstract][Full Text] [Related]
19. The neurotrophins NT3 and BDNF induce selective specification of neuropeptide coexpression and neuronal connectivity in arcuate and periventricular hypothalamic neurons in vitro.
Petit F; Huicq S; Gardette R; Epelbaum J; Loudes C; Kordon C; Faivre-Bauman A
Neuroendocrinology; 2002 Jan; 75(1):55-69. PubMed ID: 11810035
[TBL] [Abstract][Full Text] [Related]
20. Role of brain-derived neurotrophic factor in Huntington's disease.
Zuccato C; Cattaneo E
Prog Neurobiol; 2007 Apr; 81(5-6):294-330. PubMed ID: 17379385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
